Name: Contineum Therapeutics, Inc. (CTNM) Balance Sheet
Creator: FinSpry

Contineum Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Contineum Therapeutics, Inc. (CTNM) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Current Assets
Cash and Cash Equivalents	21.94	15.53	5.57	4.63
Short-Term Investments	182.82	109.66	41.67	64.37
Cash & Short-Term Investments	204.76	125.19	47.24	69.00
Accounts Receivable	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00
Other Current Assets	1.63	2.52	1.15	0.78
Total Current Assets	206.39	127.71	48.39	69.78
Non-Current Assets
Property, Plant & Equipment (Net)	6.46	1.40	2.12	0.64
Other Non-Current Assets	0.00	1.28	0.13	0.10
Total Non-Current Assets	6.46	2.68	2.24	0.74
Total Assets	212.85	130.39	50.64	70.52
Current Liabilities
Accounts Payable	1.81	0.64	0.43	0.66
Short-Term Debt	1.45	0.00	3.95	1.25
Current Portion of Long-Term Debt	0.00	0.00	3.95	1.25
Accrued Liabilities	6.71	4.39	2.06	1.69
Other Current Liabilities	6.71	0.00	0.00	0.08
Total Current Liabilities	9.97	5.48	7.55	3.67
Non-Current Liabilities
Long-Term Debt	4.81	0.11	0.79	3.66
Other Non-Current Liabilities	0.00	0.11	3.03	1.60
Total Non-Current Liabilities	4.81	192.84	136.30	137.74
Total Liabilities	14.78	5.70	11.37	8.93
Stockholders' Equity
Common Stock	0.03	0.00	0.01	0.01
Retained Earnings	-117.40	-75.14	-97.86	-73.61
Accumulated Other Comprehensive Income	0.07	0.11	-0.08	-0.04
Additional Paid-in Capital	315.37	7.10	4.73	2.74
Shares Outstanding	25.85	27.06	27.06	27.06
Total Stockholders' Equity	198.07	124.68	39.27	61.59
Total Liabilities & Equity	212.85	130.39	50.64	70.52